Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Three UFS researchers attend cactus pear congress
2017-05-05

Description: Dr de Wit Cactus pear 2 Tags: Dr de Wit Cactus pear 2

Dr Maryna de Wit, one of the
UFS delegation team was appointed
coordinator for Agro-Processing
and Post-Harvest Technology during
the congress

Description: Dr du Toit Cactus Pear 2 Tags: Dr du Toit Cactus Pear 2

Dr Alba du Toit, also one of the members
of the UFS delegation during the
congress at the University of Chile
in Santiago, Chile.
Photos: Supplied





Dr Alba du Toit, a junior lecturer in Consumer Science at the University of the Free State (UFS), presented her research at the recent IX International Congress on Cactus Pear and Cochineal at the University of Chile in Santiago, Chile. The congress was themed, “CAM Crops for a Hotter and Drier World”.

Dr Du Toit, Prof HO de Waal and Dr Maryna de Wit, from the Faculty of Natural and Agricultural Sciences at UFS, attended the five-day conference held between 26 and 30 March 2017.

Congress a platform for networking
The congress, held every three years since 1993, gathers cactus pear researchers, growers and processing managers from Europe, the Americas, Asia and Africa to review current research trends by networking to form new collaborations that could lead to increased efficiency and shared knowledge. They also present new findings and plan for future research.

Great achievements for researchers
Dr Du Toit said: “My research on cactus pears focused on the utilisation of the slimy substance found in the cactus cladodes as a functional ingredient in innovative nutraceutical food products”. Functional foods are foods that promote health or prevent disease through adding or omitting specific ingredients. She also received the International Society of Horticultural Science award for best student oral presentation.

Dr De Wit also presented her research and was appointed coordinator for Agro-Processing and Post-Harvest Technology at the congress.

Dr Herman Fouché, Affiliated Researcher at the Department of Soil-, Crop- and Climate Sciences at UFS, developed “kuilmoes”, a type of silage from pulped cactus pear fruit, mixed with lucerne, in collaboration with Prof de Waal, which was also presented.at the congress.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept